Keywords:
Anxiety disorders, post-traumatic stress disorder, mental health, anti-anxiety treatment
Abstract
Post-traumatic stress disorder (PTSD) and anxiety disorders are common psychiatric disorders worldwide, with a prevalence of 44.8 million cases in Africa. Their prevelance continues to increase over the years, with the major surge noticed during and after the COVID 19 pandemic. Emerging evidence indicates a strong association between anxiety disorders, including PTSD, with suicidal behaviour. Hence, they both have substantial impact on the individual and society. Thus, a comprehensive understanding of the management of these conditions is crucial. This review provides an overview of PTSD and anxiety disorders, focusing on their pharmacological and non pharmacological management.
Author Biographies
PP Skosana, Sefako Makgatho Health Sciences University
Department of Clinical Pharmacy, School of Pharmacy, Sefako Makgatho Health Sciences University, South Africa
S Mokhele, Sefako Makgatho Health Sciences University
Department of Pharmaceutical Sciences, School of Pharmacy, Sefako Makgatho Health Sciences University, South Africa
J Andrew, Sefako Makgatho Health Sciences University
Department of Pharmaceutical Sciences, School of Pharmacy, Sefako Makgatho Health Sciences University, South Africa
LA Zikalala-Mabope, Sefako Makgatho Health Sciences University
Office of the Dean, School of Pharmacy, Sefako Makgatho Health Sciences University, South Africa
PP Lentsoane, Sefako Makgatho Health Sciences University
Department of Clinical Pharmacy, School of Pharmacy, Sefako Makgatho Health Sciences University, South Africa
V Abraham, Sefako Makgatho Health Sciences University
Department of Pharmaceutical Sciences, School of Pharmacy, Sefako Makgatho Health Sciences University, South Africa
